Abstract:The intensity and character of concerns about antibiotic resistance, over the past nearly seventy-five years, have depended on a series of linked factors: the evolution and distribution of resistant microbes themselves; our differential capacity and efforts to detect such microbes; evolving models of antibiotic resistance and the related projected impact of antibiotic resistance on medical, social, and economic futures; the linkages of antibiotic prescribing and usage to the prevailing practice and identities of the medical and veterinary professions, and to the practice of agribusiness; the projected capacity of biomedicine (and especially the pharmaceutical industry) to stay ahead of such developing resistance; the perceived global context in which such resistance has developed; and the coordination of efforts and the development of infrastructure and funding to draw attention to and confront such microbial resistance. This paper traces the evolving response to antibiotic resistance through what at this point appear to be five eras: that between 1945 and 1963, a relatively optimistic period during which time the pharmaceutical industry appeared to most as capable of keeping up with antibiotic resistance; that between 1963 and 1981, characterized by increasing concern (though limited reformist activity) in the wake of the discovery of the transmission of antibiotic resistance via extrachromosomal plasmids; that between 1981 and 1992, notable for the explicit framing of antibiotic resistance as a shared global problem by such reformers as Stuart Levy and the Alliance for the Prudent Use of Antibiotics; that from 1992 through 2013, during which time antibiotic resistance became linked to larger concerns regarding emerging infections and received increasing collective attention and funding; and that from 2013 through to the present, with antibiotic resistance still more palpably and publicly embedded within larger concerns over global emerging infections, social justice, and development goals, attracting interest from a diverse cohort of actors.

From Fluctuations and Disorder to Scaling and Control: The Emergence of Resistance in Microbial Communities

Antibiotic resistance: Insights from evolution experiments and mathematical modeling

Coupled environmental and demographic fluctuations shape the evolution of cooperative antimicrobial resistance

Ecology and evolution of antimicrobial resistance in bacterial communities

Understanding the Evolution and Transmission Dynamics of Antibiotic Resistance Genes: A Comprehensive Review

Bacterial Resistance and Human Microecology

Dynamical model of antibiotic responses linking expression of resistance genes to metabolism explains emergence of heterogeneity during drug exposures

Defining and combating antibiotic resistance from One Health and Global Health perspectives

Eco-evolutionary dynamics of cooperative antimicrobial resistance in a population of fluctuating volume and size

Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health

Community interactions and spatial structure shape selection on antibiotic resistant lineages

Emergence of Resistant Escherichia coli Mutants in Microfluidic On-Chip Antibiotic Gradients

Man vs Microbes - The Race of the Century

The evolving response to antibiotic resistance (1945–2018)

Social Interaction, Noise and Antibiotic-Mediated Switches in the Intestinal Microbiota

Microbial interactions affect the tempo and mode of antibiotic resistance evolution

Biphasic adaptive evolution of antimicrobial resistance

Predicting the evolution of antibiotic resistance

Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance

The past, present and future of polymicrobial infection research: Modelling, eavesdropping, terraforming and other stories